Conferences

ecancer travels so that you don't have to. Expore the latest conference coverage in global oncology and find out where we are going next.
Bookmark and Share

iwCLL 2015

7 - 9 Sep 2015
Hilton Hotel Sydney, Sydney, Australia
Results of an analysis study into CLL mutations
Prof Catherine Wu - Harvard Medical School, Boston, USA
Results of an analysis study into CLL mutations ( Prof Catherine Wu - Harvard Medical School, Boston, USA )
30 Nov 2015
Roundtable discussion on CLL: Expert insights from the iwCLL congress
Dr Paula Cramer, Prof Robin Foà, Dr Steve Coutre, Dr Constantine Tam
Roundtable discussion on CLL: Expert insights from the iwCLL congress ( Dr Paula Cramer, Prof Robin Foà, Dr Steve Coutre, Dr Constantine Tam )
2 Oct 2015
Atrial fibrillation in CLL patients on ibrutinib
Prof Florence Cymbalista – University of Paris, Paris, France
Atrial fibrillation in CLL patients on ibrutinib ( Prof Florence Cymbalista – University of Paris, Paris, France )
10 Sep 2015
Circulating levels of tumour DNA in plasma may help monitor treatment response a...
Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia
Circulating levels of tumour DNA in plasma may help monitor treatment response and resistance in CLL ( Dr Constantine Tam – Peter MacCallum Cancer Centre, Melbourne, Australia )
10 Sep 2015
Tumour specific immunotherapy in CLL
Prof Catherine Wu - Harvard Medical School, Boston, USA
Tumour specific immunotherapy in CLL ( Prof Catherine Wu - Harvard Medical School, Boston, USA )
9 Sep 2015
Highlights from iwCLL 2015
Prof Stephen Mulligan - CLL Australian Research Consortium, Sydney, Australia
Highlights from iwCLL 2015 ( Prof Stephen Mulligan - CLL Australian Research Consortium, Sydney, Australia )
9 Sep 2015
Cytogenetic and proteomic prognostic markers of CLL
Dr Lauren Thurgood - Flinders University, Adelaide, South Australia
Cytogenetic and proteomic prognostic markers of CLL ( Dr Lauren Thurgood - Flinders University, Adelaide, South Australia )
9 Sep 2015
Predicting progression and survival in CLL
Prof Jonathan Strefford - University of Southampton, Southampton, UK
Predicting progression and survival in CLL ( Prof Jonathan Strefford - University of Southampton, Southampton, UK )
9 Sep 2015
Phase I study of duvelisib in patients with relapsed or refractory CLL
Dr Susan O’Brien – University of California, Irvine, California, USA
Phase I study of duvelisib in patients with relapsed or refractory CLL ( Dr Susan O’Brien – University of California, Irvine, California, USA )
9 Sep 2015
The LRF CLL4 trial: long-term outcomes
Prof Daniel Catovsky - The Institute of Cancer Research, London, UK
The LRF CLL4 trial: long-term outcomes ( Prof Daniel Catovsky - The Institute of Cancer Research, London, UK )
9 Sep 2015
Expert panel discussion: The best of iwCLL 2015
Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai
Expert panel discussion: The best of iwCLL 2015 ( Prof John Gribben, Prof Michael Hallek, Dr Michael Keating, Prof Kanti Rai )
9 Sep 2015
Targeting the NEDD8-activating enzyme to induce apoptosis in CLL cells
Dr Alexey Danilov - Oregon Health and Science University, Portland, USA
Targeting the NEDD8-activating enzyme to induce apoptosis in CLL cells ( Dr Alexey Danilov - Oregon Health and Science University, Portland, USA )
9 Sep 2015
Genetic deletions in CLL
Dr Carlo Croce - The Ohio State University College of Medicine, Columbus, USA
Genetic deletions in CLL ( Dr Carlo Croce - The Ohio State University College of Medicine, Columbus, USA )
9 Sep 2015
High remission rates for new CLL treatment
Prof John Seymour - Peter MacCallum Cancer Centre, Victoria, Australia
High remission rates for new CLL treatment ( Prof John Seymour - Peter MacCallum Cancer Centre, Victoria, Australia )
9 Sep 2015
CLL from a patient and physician perspective
Dr Brian Koffman MD – Medical Director of the CLL Society
CLL from a patient and physician perspective ( Dr Brian Koffman MD – Medical Director of the CLL Society )
9 Sep 2015
The changing landscape of the young investigator meeting at iwCLL 2015
Dr Giles Best and Prof Arnon Kater
The changing landscape of the young investigator meeting at iwCLL 2015 ( Dr Giles Best and Prof Arnon Kater )
8 Sep 2015
Ethnic variations in CLL prevalence
Dr Thomas Chan - Queen Mary Hospital, Hong Kong, China
Ethnic variations in CLL prevalence ( Dr Thomas Chan - Queen Mary Hospital, Hong Kong, China )
8 Sep 2015
Risk of bleeding-related adverse events in ibrutinib treated CLL patients
Dr Adrian Weistner - National Heart, Lung and Blood Institute, Maryland, USA
Risk of bleeding-related adverse events in ibrutinib treated CLL patients ( Dr Adrian Weistner - National Heart, Lung and Blood Institute, Maryland, USA )
8 Sep 2015
Crystallography of the B-cell receptor immunoglobulin in CLL patients
Prof Paolo Ghia - San Raffaele University, Milan, Italy
Crystallography of the B-cell receptor immunoglobulin in CLL patients ( Prof Paolo Ghia - San Raffaele University, Milan, Italy )
8 Sep 2015
Epidemiology of CLL: Interlymph consortium and genome-wide sequencing studies
Prof Claire Vajdic - University of New South Wales, Sydney, Australia
Epidemiology of CLL: Interlymph consortium and genome-wide sequencing studies ( Prof Claire Vajdic - University of New South Wales, Sydney, Australia )
8 Sep 2015
Harmonisation of CLL diagnosis and detection of residual disease monitoring by f...
Dr Andrew Rawstron - St James Institute of Oncology, Leeds, UK
Harmonisation of CLL diagnosis and detection of residual disease monitoring by flow cytometry ( Dr Andrew Rawstron - St James Institute of Oncology, Leeds, UK )
8 Sep 2015
Results of subgroup analysis of the HELIOS trial
Dr Paula Cramer – University of Cologne, Cologne, Germany
Results of subgroup analysis of the HELIOS trial ( Dr Paula Cramer – University of Cologne, Cologne, Germany )
8 Sep 2015
Primary results from the MABLE phase IIIb study
Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France
Primary results from the MABLE phase IIIb study ( Dr Anne-Sophie Michallet - Centre Hospitalier Lyon-Sud, Lyon, France )
8 Sep 2015
Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecu...
Dr Amy Johnson – The Ohio State University, Columbus, USA
Highlights from the iwCLL conference: B-cell receptor Btk, PI3K and multi-molecular BCR inhibitors ( Dr Amy Johnson – The Ohio State University, Columbus, USA )
8 Sep 2015
Results of a new phase Ib trial of voxtalisib in combination with chemoimmunothe...
Prof Farrukh Awan - Ohio State University, Columbus, USA
Results of a new phase Ib trial of voxtalisib in combination with chemoimmunotherapy ( Prof Farrukh Awan - Ohio State University, Columbus, USA )
8 Sep 2015
A laboratory model of the hypoxic tumour microenvironment
Dr Giles Best - Royal North Shore Hospital, Sydney, Australia
A laboratory model of the hypoxic tumour microenvironment ( Dr Giles Best - Royal North Shore Hospital, Sydney, Australia )
8 Sep 2015
Will chemotherapy remain the cornerstone of CLL management?
Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany
Will chemotherapy remain the cornerstone of CLL management? ( Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany )
8 Sep 2015
New research into new small molecule IKKα inhibitors
Dr Elaine Willmore – University of Newcastle, Newcastle, UK
New research into new small molecule IKKα inhibitors ( Dr Elaine Willmore – University of Newcastle, Newcastle, UK )
8 Sep 2015
Phase II study of idelalisib monotherapy in older CLL patients
Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA
Phase II study of idelalisib monotherapy in older CLL patients ( Dr Andrew Zelenetz – Memorial Sloan Kettering Cancer Center, New York, USA )
7 Sep 2015
History of the B-cell in its 50th anniversary year
Prof Max Cooper - Emory University, Atlanta, USA
History of the B-cell in its 50th anniversary year ( Prof Max Cooper - Emory University, Atlanta, USA )
7 Sep 2015
Human B-cell receptor structure and function in CLL
Prof Freda Stevenson - University of Southampton, Southampton, UK
Human B-cell receptor structure and function in CLL ( Prof Freda Stevenson - University of Southampton, Southampton, UK )
7 Sep 2015
Translational research and the future of CLL treatment
Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA
Translational research and the future of CLL treatment ( Prof Steven Coutré – Stanford University School of Medicine, Stanford, USA )
7 Sep 2015
The role of CLL cells, T-cells and macrophages and their effects on the tumour m...
Prof Arnon Kater - Academic Medical Center, Amsterdam, The Netherlands
The role of CLL cells, T-cells and macrophages and their effects on the tumour microenvironment ( Prof Arnon Kater - Academic Medical Center, Amsterdam, The Netherlands )
7 Sep 2015